Pegasus Partners Ltd. Johnson & Johnson Transaction History

Pegasus Partners Ltd.

$1.07 Billion
Q3 2024

A detailed history of Pegasus Partners Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Pegasus Partners Ltd. holds 8,159 shares of JNJ stock, worth $1.28 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,159

Previous 9,931 17.84%

Holding current value

$1.28 Million

Previous $1.45 Million 8.89%

% of portfolio

0.12%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$145.48 - $167.38 $257,790 - $296,597	-1,772 Reduced 17.84%	8,159 $1.32 Million
Q2 2024 Aug 07, 2024	SELL	$144.38 - $157.78 $456,673 - $499,058	-3,163 Reduced 24.16%	9,931 $1.45 Million
Q1 2024 Apr 24, 2024	SELL	$155.22 - $162.74 $162,360 - $170,226	-1,046 Reduced 7.4%	13,094 $2.07 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $202,820 - $221,319	-1,393 Reduced 8.97%	14,140 $2.22 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $241,879 - $270,967	-1,553 Reduced 9.09%	15,533 $2.42 Million
Q2 2023 Aug 04, 2023	SELL	$154.35 - $166.11 $152,034 - $163,618	-985 Reduced 5.45%	17,086 $2.83 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $272,947 - $325,729	-1,807 Reduced 9.09%	18,071 $2.8 Million
Q4 2022 Feb 09, 2023	SELL	$160.2 - $179.79 $196,725 - $220,782	-1,228 Reduced 5.82%	19,878 $3.51 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $51,786 - $57,625	-321 Reduced 1.5%	21,106 $3.45 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $34,647 - $38,318	-206 Reduced 0.95%	21,427 $3.8 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $298,093 - $338,527	-1,885 Reduced 8.02%	21,633 $3.83 Million
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $636,662 - $706,399	-4,083 Reduced 14.79%	23,518 $4.02 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $523,260 - $581,482	-3,240 Reduced 10.51%	27,601 $4.46 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $865,338 - $928,225	-5,426 Reduced 14.96%	30,841 $5.08 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $1.78 Million - $1.98 Million	-11,608 Reduced 24.25%	36,267 $5.96 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $398,304 - $457,188	2,905 Added 6.46%	47,875 $7.54 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $167,052 - $183,057	1,190 Added 2.72%	44,970 $6.7 Million
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $266,507 - $321,750	2,069 Added 4.96%	43,780 $6.16 Million
Q1 2020 May 11, 2020	BUY	$111.14 - $153.99 $828,104 - $1.15 Million	7,451 Added 21.75%	41,711 $5.47 Million
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $857,565 - $984,955	6,726 Added 24.43%	34,260 $5 Million
Q3 2019 Oct 24, 2019	BUY	$126.95 - $142.14 $941,461 - $1.05 Million	7,416 Added 36.86%	27,534 $3.56 Million
Q2 2019 Jul 30, 2019	SELL	$131.15 - $144.24 $377,712 - $415,411	-2,880 Reduced 12.52%	20,118 $2.8 Million
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $197,003 - $219,050	1,567 Added 7.31%	22,998 $3.22 Million
Q4 2018 Feb 01, 2019	SELL	$122.84 - $147.84 $356,973 - $429,623	-2,906 Reduced 11.94%	21,431 $2.77 Million
Q3 2018 Nov 07, 2018	BUY	$121.58 - $142.88 $60,911 - $71,582	501 Added 2.1%	24,337 $3.36 Million
Q2 2018 Jul 27, 2018	BUY	$119.4 - $131.76 $87,759 - $96,843	735 Added 3.18%	23,836 $2.89 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $494,520 - $585,597	-3,953 Reduced 14.61%	23,101 $2.96 Million
Q4 2017 Feb 08, 2018	BUY	$131.22 - $143.62 $272,937 - $298,729	2,080 Added 8.33%	27,054 $3.78 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $3.23 Million - $3.38 Million	24,974	24,974 $3.25 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.

Account

Pegasus Partners Ltd. Johnson & Johnson Transaction History